ArticleScientific reports2025
Potential of tadalafil and tadalafil-cellulose nanocomposite in preventing postsurgical abdominal adhesions in a rat cecal abrasion model.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The formation of postoperative intra-abdominal adhesions is a significant challenge in veterinary practice worldwide. Thus, several attempts have been made to identify agents that prevent the occurrence of these postsurgical adhesions. However, finding an ideal and effective agent remains a challenge. Herein, we investigate the potential of tadalafil and tadalafil/cellulose composite as promising therapeutics for preventing postsurgical intra-abdominal adhesions. A cecal abrasion model was established in 30 rats, which either left untreated or treated with tadalafil, cellulose, or tadalafil/cellulose. After 2 weeks, the adhesion formation was evaluated based on gross appearance, oxidative stress markers, pro-inflammatory cytokines, histopathological analysis, and immunohistochemical staining. Compared to the adhesion group, gross and histopathological findings revealed that both the tadalafil and cellulose groups significantly decreased adhesion formation, with better results observed after tadalafil treatment. Importantly the tadalafil/cellulose treatment completely prevented adhesion formation. Additionally, the treated groups showed reduced levels of malondialdehyde (MDA), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6), while increasing the level of reduced glutathione (GSH) compared to the adhesion group. Furthermore, the treated groups reduced the expression of macrophage markers. These findings suggest that the intra-abdominal application of tadalafil and tadalafil/cellulose following abdominal surgery holds promise as a clinical strategy to prevent postsurgical intra-abdominal adhesions, with tadalafil/cellulose demonstrating superior efficacy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.